Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
swiss-biotech
Press Release
Sep 7, 2022
BioLingus to Develop a Sublingual Vaccine for COVID in Cooperation With the Korean CHA Vaccine Institute and PanGen Biotech
Development of a sublingual COVID-19 subunit vaccine: the potential for a better protective efficacy and improved thermal stability during distribution and storage as compared to conventional COVID-19 vaccines
Read More
First
Prev
1
Next
Last